Article
FDA Issued Guidance On Statistical Considerations For Clinical Trials During The COVID-19 Public Health Emergency
On June 17, the Food and Drug Administration (FDA) continued its efforts to mitigate COVID-19's disrupting impact on clinical trials by issuing guidance on statistical considerations for changes to...
Reed Smith





